BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7489311)

  • 41. A clinical oncologic perspective on breast magnetic resonance imaging.
    Bloom S; Morrow M
    Magn Reson Imaging Clin N Am; 2010 May; 18(2):277-94, ix. PubMed ID: 20494312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy.
    Heywang-Köbrunner SH; Schlegel A; Beck R; Wendt T; Kellner W; Lommatzsch B; Untch M; Nathrath WB
    J Comput Assist Tomogr; 1993; 17(6):891-900. PubMed ID: 8227574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MR imaging of the breast for cancer evaluation. Current status and future directions.
    Stelling CB
    Radiol Clin North Am; 1995 Nov; 33(6):1187-204. PubMed ID: 7480665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic resonance imaging in potential postsurgical recurrence of breast cancer: pitfalls and limitations.
    Cohen EK; Leonhardt CM; Shumak RS; Soutar IC; Bukhanov K; Fishell EK; Plewes DB
    Can Assoc Radiol J; 1996 Jun; 47(3):171-6. PubMed ID: 8640412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contrast media in breast imaging.
    Serrano LF; Morrell B; Mai A
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):777-89. PubMed ID: 23088950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MR imaging of the breast with Gd-DTPA enhancement: comparison with mammography and ultrasonography.
    Hachiya J; Seki T; Okada M; Nitatori T; Korenaga T; Furuya Y
    Radiat Med; 1991; 9(6):232-40. PubMed ID: 1668410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging.
    Dao TH; Rahmouni A; Campana F; Laurent M; Asselain B; Fourquet A
    Radiology; 1993 Jun; 187(3):751-5. PubMed ID: 8497625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients.
    Gilles R; Guinebretière JM; Shapeero LG; Lesnik A; Contesso G; Sarrazin D; Masselot J; Vanel D
    Radiology; 1993 Aug; 188(2):473-8. PubMed ID: 8327700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gadolinium-enhanced breast MRI.
    Kelcz F; Santyr G
    Crit Rev Diagn Imaging; 1995; 36(4):287-338. PubMed ID: 8845065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MR imaging of the breast in patients with occult primary breast carcinoma.
    Morris EA; Schwartz LH; Dershaw DD; van Zee KJ; Abramson AF; Liberman L
    Radiology; 1997 Nov; 205(2):437-40. PubMed ID: 9356625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The postconservation breast: part 2, Imaging findings of tumor recurrence and other long-term sequelae.
    Chansakul T; Lai KC; Slanetz PJ
    AJR Am J Roentgenol; 2012 Feb; 198(2):331-43. PubMed ID: 22268175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model.
    Tofts PS; Berkowitz B; Schnall MD
    Magn Reson Med; 1995 Apr; 33(4):564-8. PubMed ID: 7776889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Contrast enhancement of the nipple in nuclear magnetic resonance tomography of the breast with Gd-DTPA].
    Beck R; Heywang SH; Eiermann W; Permanetter W; Lissner J
    Digitale Bilddiagn; 1987 Dec; 7(4):167-9. PubMed ID: 3436118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions.
    Boné B; Péntek Z; Perbeck L; Veress B
    Acta Radiol; 1997 Jul; 38(4 Pt 1):489-96. PubMed ID: 9240665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Value of MR mammography in the detection and exclusion of recurrent breast carcinoma.
    Rieber A; Merkle E; Zeitler H; Görich J; Kreienberg R; Brambs HJ; Tomczak R
    J Comput Assist Tomogr; 1997; 21(5):780-4. PubMed ID: 9294575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gd-DTPA enhanced MR imaging of the breast in patients with postoperative scarring and silicon implants.
    Heywang SH; Hilbertz T; Beck R; Bauer WM; Eiermann W; Permanetter W
    J Comput Assist Tomogr; 1990; 14(3):348-56. PubMed ID: 2335598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A review of breast imaging following mastectomy with or without reconstruction in an outpatient community center.
    Destounis S; Morgan R; Arieno A; Seifert P; Somerville P; Murphy P
    Breast Cancer; 2011 Oct; 18(4):259-67. PubMed ID: 21695517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Scar or recurrence--comparison of MRI and color-coded ultrasound with echo signal amplifiers].
    Aichinger U; Schulz-Wendtland R; Krämer S; Lell M; Bautz W
    Rofo; 2002 Nov; 174(11):1395-401. PubMed ID: 12424666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How to optimize clinical breast MR imaging practices and techniques on Your 1.5-T system.
    Rausch DR; Hendrick RE
    Radiographics; 2006; 26(5):1469-84. PubMed ID: 16973776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MR spectroscopy and imaging of breast cancer. A brief history.
    Turner DA
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):505-10. PubMed ID: 7489304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.